A part virtual, part live board room meeting with a group of professionals discussing a presentation.

LEADERSHIP

Our management team.

Atea is led by a team of highly experienced antiviral drug discoverers, developers and company builders, each bringing a unique, highly informed perspective. We share an unwavering commitment to the rapid advancement of each of our therapeutic programs – from discovery through approval and commercialization.

A headshot of Jean-Pierre Sommadossi, PhD

FOUNDER, CHAIRMAN & CEO

Jean-Pierre Sommadossi, PhD

Full Bio
A headshot of Nancy Agrawal, PhD

Executive VP, Preclinical Development

Nancy Agrawal, PhD

Full Bio
A headshot of Jonae Barnes

Senior VP, Investor Relations & Corporate Communications

Jonae Barnes

Full Bio
A headshot of Bruce Belanger, PhD

Senior VP, Biostatistics

Bruce Belanger, PhD

Full Bio
A headshot of Andrea Corcoran

CFO & Executive VP, Legal

Andrea Corcoran

Full Bio
A headshot of Adam DeZure, MD

VP, Clinical Development

Adam DeZure, MD

Full Bio
A headshot of James MB Evans, PhD

VP, CMC Manufacturing

James MB Evans, PhD

Full Bio
A headshot of Wayne Foster

EXECUTIVE VP, Chief Accounting Officer

Wayne Foster

Full Bio
A headshot of Kerry Gagnon

VP, Head of Quality

Kerry Gagnon

Full Bio
A headshot of Steven Good

EXECUTIVE VP, PRECLINICAL SCIENCE

Steven Good

Full Bio
A headshot of Janet Hammond, MD, PhD

CHIEF DEVELOPMENT OFFICER

Janet Hammond, MD, PhD

Full Bio
A headshot of Arantxa Horga, MD

Chief Medical Officer

Arantxa Horga, MD

Full Bio
A headshot of Qi Huang

Senior VP, Virology

Qi Huang

Full Bio
A headshot of Laura Ishak

Senior VP, Clinical Operations

Laura Ishak

Full Bio
A headshot of Ariyapadi Krishnaraj

VP, Marketing

Ariyapadi Krishnaraj

Full Bio
A headshot of Adel Moussa, PhD

EXECUTIVE VP, CHEMISTRY

Adel Moussa, PhD

Full Bio
A headshot of Shari Noble

VP, Deputy General Counsel

Shari Noble

Full Bio
A headshot of Keith Pietropaolo

Executive VP, Clinical Sciences and Project Management

Keith Pietropaolo

Full Bio
A headshot of Brian Rowe

VP, Business Development

Brian Rowe

Full Bio
A headshot of Marc Van Hulle

VP, Finance

Marc Van Hulle

Full Bio
A headshot of John Vavricka

CHIEF COMMERCIAL OFFICER

John Vavricka

Full Bio
A headshot of Alex Vo, PhD

VP, DMPK

Alex Vo, PhD

Full Bio
A headshot of Jayanthi Wolf, PhD

Executive VP, Regulatory Affairs

Jayanthi Wolf, PhD

Full Bio
A headshot of Xiao-Jian Zhou, PhD

EXECUTIVE VP, EARLY STAGE DEVELOPMENT

Xiao-Jian Zhou, PhD

Full Bio

Board of Directors

Jean-Pierre Sommadossi, PhD

CHAIRMAN & CEO, ATEA PHARMACEUTICALS

Jerome Adams, M.D., M.P.H.

Former Surgeon General of the United States

Franklin Berger, CFA

FOUNDING & MANAGING DIRECTOR, FMB RESEARCH

Barbara Duncan

Former CFO, Intercept Pharmaceuticals

Bruno Lucidi

LIFE SCIENCES EXPERT, WALLONIA TRADE AND FOREIGN INVESTMENT AGENCY (AWEX)

Polly A. Murphy, DVM, PhD

Chief Business Officer, Avadel Pharmaceuticals plc

Bruce Polsky, MD, MACP, FIDSA

PROFESSOR AND CHAIRMAN, DEPARTMENT OF MEDICINE, NYU LANGONE HOSPITAL – LONG ISLAND; ASSOC. DEAN, FACULTY, NYU Grossman Long Island School of Medicine

Atea is a clinical-stage biopharmaceutical company committed to addressing unmet medical needs through novel antiviral treatments.

Copyright © 2023 By Atea Pharmaceuticals. All Rights Reserved. Privacy Policy | Terms of Use